filo Novavax ( NVAX ) shares added ~6% in the premarket on Wednesday after the COVID-19 vaccine maker well exceeded Street forecasts with its Q1 financials, thanks to a licensing deal with Pfizer ( PFE ) reached earlier this year. The Gaithersburg, Maryland biotech said that the Pfizer ( PFE ) deal that allowed the pharma giant to use its Matrix-M adjuvant added $30M to the topline, expanding its ...
filo Novavax ( NVAX ) shares added ~6% in the premarket on Wednesday after the COVID-19 vaccine maker well exceeded Street forecasts with its Q1 financials, thanks to a licensing deal with Pfizer ( PFE ) reached earlier this year. The Gaithersburg, Maryland biotech said that the Pfizer ( PFE ) deal that allowed the pharma giant to use its Matrix-M adjuvant added $30M to the topline, expanding its licensing royalties and other revenue to $97.3M during the period with over 116% year-over-year growth. However, the company’s total revenue for Q1 fell ~79% YoY to $139.5M, still exceeding the consensus by $58.5M even though sales from its COVID-19 shot, Nuvaxovid, marketed with Sanofi ( SNY ), plunged. Novavax ( NVAX ) attributed the sales decline mainly to $603M of non-cash sales recognized for Nuvaxovid with the close-out of two advance purchase agreements in the prior-year period. As a result, the company recorded $621.7M in product sales in Q1 2025 compared to $42.2M in the last quarter. However, in the absence of strong sales, the company swung to a net loss of $9.5M compared to $518.6M of net income in Q1 2025. While reiterating the full-year revenue guidance, Novavax ( NVAX ) increased its 2028 expense reduction projection to more than $500M, citing progress in its ongoing cost-cutting program. On the R&D front, NVAX announced plans to prioritize its vaccine candidate targeting clostridioides difficile colitis (C. difficile) as its next potential asset. The clinical development of the vaccine is expected to begin in 2027. More on Novavax, Pfizer Pfizer Inc. (PFE) Q1 2026 Earnings Call Transcript Pfizer Q1 Earnings Review: Stuck In Second Gear, But Dividend Helps Pfizer Inc. 2026 Q1 - Results - Earnings Call Presentation FDA halts publication of studies on COVID, shingles vaccines Pfizer expects $59.5B-$62.5B 2026 revenue, cites post-2028 high single-digit CAGR visibility after Vyndamax settlement
U.S. Treasury yields moved sharply lower on Wednesday morning as investors responded to signs of easing geopolitical tensions in the Middle East and a rebound in equity futures ahead of the opening bell. Reports indicating that the U.S. and Iran are nearing a one-page memorandum of understanding aimed at ending the conflict between the two nations helped improve overall market sentiment, driving d...
U.S. Treasury yields moved sharply lower on Wednesday morning as investors responded to signs of easing geopolitical tensions in the Middle East and a rebound in equity futures ahead of the opening bell. Reports indicating that the U.S. and Iran are nearing a one-page memorandum of understanding aimed at ending the conflict between the two nations helped improve overall market sentiment, driving demand away from traditional safe-haven assets. U.S. equity markets look poised to open higher following the development, while Treasury yields declined across the curve. The rate-sensitive U.S. 2 Year Treasury yield ( US2Y ) fell 7 basis points to 3.87%. Meanwhile, the benchmark U.S. 10 Year Treasury yield ( US10Y ) also dropped 7 basis points to 4.35%, reflecting growing expectations that cooling geopolitical risks and softer commodity prices could ease inflation concerns. The U.S. 30 Year Treasury yield ( US30Y ) declined 5 basis points to 4.93%, slipping back below the key 5% threshold. Further supporting the move lower in yields was a steep decline in oil ( CL1:COM ) prices. Crude oil tumbled roughly 7.5% in early trading, falling below $100 per barrel as hopes for broader Middle East de-escalation gained momentum. Fixed Income ETFs: ( TLT ), ( TLH ), ( IEF ), ( IEI ), ( SHY ), ( SGOV ), ( SCHO ), ( BIL ), ( AGG ), ( BND ), ( VCIT ), ( MUB ), ( MBB ), ( JNK ), ( LQD ), ( HYG ), ( VTIP ), ( TIP ), ( SCHP ), ( STIP ), ( TIPX ), ( SPIP ), ( WIP ), ( GTIP ), ( LQDI ), and ( RINF ). More on markets Strait of Hormuz reopening odds jump as U.S.-Iran deal talks advance Samsung joins the $1 trillion club as Apple chip talks spark rally Chip stocks post best 25-day stretch since 2000, and these 10 names are standing out ETF inflows surge: U.S. funds pull in $174B in April as equity demand accelerates Elon Musk vs. OpenAI case: Prediction markets turn bearish on Musk
Luis Alvarez Stock index futures rose Wednesday as investor sentiment improved on hopes of easing tensions between the U.S. and Iran. Here are the four stocks to watch on the day: Arista Networks ( ANET ) fell about 9% in premarket trading despite posting a first-quarter beat and receiving largely positive analyst commentary. The networking company delivered revenue of $2.71 billion and earnings p...
Luis Alvarez Stock index futures rose Wednesday as investor sentiment improved on hopes of easing tensions between the U.S. and Iran. Here are the four stocks to watch on the day: Arista Networks ( ANET ) fell about 9% in premarket trading despite posting a first-quarter beat and receiving largely positive analyst commentary. The networking company delivered revenue of $2.71 billion and earnings per share of $0.87, exceeding Wall Street estimates of $2.62 billion and $0.81, respectively, with overall growth coming in at approximately 35% year-over-year. J.P. Morgan maintained its Overweight rating and $200 price target, while Evercore kept its Outperform rating and $200 target, though analysts highlighted supply constraints as a concern. Novo Nordisk ( NVO ) gained 5.98% in premarket trading after the Danish drugmaker raised its full-year outlook on strong early demand for its oral Wegovy pill. The revised guidance helped revive momentum in the company’s obesity business, with adjusted sales and operating profit now expected to contract between 4% and 12%, an improvement from the earlier forecast of a 5% to 13% year-over-year decline. AMC Entertainment ( AMC ) rose about 8% in premarket trading after the theater chain reported a smaller quarterly loss aided by a rebound in moviegoing. Revenue climbed 21.7% to $1.05 billion, beating estimates, while net loss narrowed to $117.1 million from $202.1 million a year earlier. Adjusted EBITDA turned positive at $38.3 million, compared with a loss in the prior-year period. Restaurant Brands International ( QSR ) gained in early trading after topping estimates on both lines of its first-quarter earnings report. The parent company of Burger King posted system-wide sales growth of 6.2% and comparable sales growth of 3.2%, exceeding the consensus expectation of 3.0%, driven by a 5.8% increase in the Burger King segment. More related stories Novo Nordisk A/S 2026 Q1 - Results - Earnings Call Presentation AMC Entertainment Dilutio...
When dividend stocks are struggling and trading at reduced valuations, there's a big incentive to load up on them. At lower share prices, not only could they generate better returns, but their yields are also higher. If you've got $5,000 that you can afford to invest in dividend stocks , three attractive options to consider right now are McDonald's (NYSE: MCD) , Procter & Gamble (NYSE: PG) , and A...
When dividend stocks are struggling and trading at reduced valuations, there's a big incentive to load up on them. At lower share prices, not only could they generate better returns, but their yields are also higher. If you've got $5,000 that you can afford to invest in dividend stocks , three attractive options to consider right now are McDonald's (NYSE: MCD) , Procter & Gamble (NYSE: PG) , and Abbott Laboratories (NYSE: ABT) . These stocks are all trading near their 52-week lows, and here's why they can be excellent additions to your portfolio. Image source: Getty Images. Continue reading
United States Antimony ( UAMY ) said on Wednesday it had appointed Shawn Winkler as interim CFO effective May 4, 2026, as SVP and CFO Richard Isaak commenced a temporary personal leave of absence. Isaak’s leave is for personal reasons, unrelated to the company's financials or controls, and he is expected to return after a minimum two-month period. The company remains on track to report Q1 2026 res...
United States Antimony ( UAMY ) said on Wednesday it had appointed Shawn Winkler as interim CFO effective May 4, 2026, as SVP and CFO Richard Isaak commenced a temporary personal leave of absence. Isaak’s leave is for personal reasons, unrelated to the company's financials or controls, and he is expected to return after a minimum two-month period. The company remains on track to report Q1 2026 results on May 14, with Winkler having worked closely with Isaak and the finance team—fully prepared to lead financial reporting and the earnings call. Winkler brings 15 years of experience, including as CFO of Burrow Global, along with many years in investment banking, advising on more than $10B0B in M&A and leading equity and debt capital raises. Shares -5.11%. More on United States Antimony United States Antimony: Policy-Driven Demand Creates A Rare Mining Opportunity United States Antimony: National Security Tailwinds Power The Bull Case United States Antimony Corporation (UAMY) Q4 2025 Earnings Call Transcript United States Antimony targets $125M 2026 revenue with expanded contracts and mining projects U.S. Antimony wins $27M government contract for critical minerals
(RTTNews) - Stocks are likely to move to the upside in early trading on Wednesday, extending the advance seen over the course of the previous session. The major index futures are currently pointing to a higher open for the markets, with the S&P 500 futures up by 0.8 percent.
(RTTNews) - Stocks are likely to move to the upside in early trading on Wednesday, extending the advance seen over the course of the previous session. The major index futures are currently pointing to a higher open for the markets, with the S&P 500 futures up by 0.8 percent.
halbergman/iStock via Getty Images It’s been almost two years since the last time I covered TXO Partners ( TXO ), and I thought it would be good to revisit it once again, given that it just reported its Q1 earnings and raised its dividend. Since then, the company cut its dividend, and its share price declined 33%, but the total return was -19%. TXO Partners Q1 2026 earnings The top line numbers ca...
halbergman/iStock via Getty Images It’s been almost two years since the last time I covered TXO Partners ( TXO ), and I thought it would be good to revisit it once again, given that it just reported its Q1 earnings and raised its dividend. Since then, the company cut its dividend, and its share price declined 33%, but the total return was -19%. TXO Partners Q1 2026 earnings The top line numbers came in at $28.2m, down 66% from the same time last year. You may also see that Oil and condensate are somehow negative on the 10Q , and ask yourself how this could be? The answer is a little complicated, but put simply, the management entered into a bunch of derivative contracts to hedge its oil position, ultimately yielding an average sale price for oil and condensate of around -$2.10 per Bbl, and unrealized losses of $84.2m for the quarter. The reason why its price was -$2.10 is because their derivative contracts ended up losing more (on paper) than the company managed to sell the oil for. Average sale price excluding the effects of derivatives was stable at $68.54, but the company lost $70.64. On the other hand, excluding the hedging strategy, we can see that the company sold a lot more this time around, across the board, with oil and condensate increased by 45%, natural gas liquids increased by 44%, and natural gas increased by 3.4%. Overall operations were healthy. The company only sacrificed some of the upsides for downside protection. TXO 10Q Let’s take a look at the company’s financial situation. TXO finished the year with $7.8m in cash and equivalents, and $277m in long-term debt. The interest expense it pays on that debt was $5.7m for the latest quarter. On paper, operations aren’t able to cover these obligations, but if we look at the company’s cash flows, we can see that for the quarter, TXO made $33.4m in operating cash flows, which is more than enough to cover the interest paid on the debt. We can see that the company’s cash generation ability is rather strong ...
OpenAI Co-Founder Greg Brockman Defends Company's For-Profit Pivot... And His Own $30 Billion Payday Authored by Beige Luciano-Adams via The Epoch Times, In the second week of a high-profile jury trial that could have profound impact on the race for artificial intelligence, OpenAI president Greg Brockman rejected allegations that he and other co-founders betrayed the company’s philanthropic missio...
OpenAI Co-Founder Greg Brockman Defends Company's For-Profit Pivot... And His Own $30 Billion Payday Authored by Beige Luciano-Adams via The Epoch Times, In the second week of a high-profile jury trial that could have profound impact on the race for artificial intelligence, OpenAI president Greg Brockman rejected allegations that he and other co-founders betrayed the company’s philanthropic mission and illegally enriched themselves by flipping the non-profit lab into a for-profit corporation. Tesla CEO Elon Musk in 2024 sued Brockman and CEO Sam Altman, alleging they bilked him of $38 million in donations then restructured as a for-profit corporation by exclusively licensing their flagship product to Microsoft—betraying a founding mission to operate as an open-source charity that would counter the risks of profit-driven AI. OpenAI and Microsoft deny the allegations, arguing that Musk abandoned the company in 2018 to start his own for-profit competitor, xAI, when other founders rejected his bid to take full control of the operation. “I think we’ve been very consistent on the mission,” Brockman told a federal court in Oakland. “If you look at what we’ve accomplished—currently the foundation has $150 billion worth of OpenAI equity value. That’s something we’ve built through hard blood, sweat, and tears through all this time since Elon left.” The company’s nonprofit foundation has a 27 percent stake in OpenAI’s for-profit corporation; Microsoft, which has invested more than $13 billion since 2019, owns 26 percent. Called as an adverse witness for the plaintiff, Brockman over two days May 4–5 offered testimony outlining an alternate narrative and timeframe than the one Musk presented the week prior. Brockman also attempted to add context to what he has claimed were “cherrypicked” segments of his personal diary, unsealed during the discovery process. He often spoke in incomplete sentences, punctuated by stock phrases like, “We were solving for the mission.” Arguably, this...
Capital One stock faces rising credit risk as the Discover purchase reshapes its business, leaving investors weighing benefits against long-term upside.
Capital One stock faces rising credit risk as the Discover purchase reshapes its business, leaving investors weighing benefits against long-term upside.
bymuratdeniz/iStock via Getty Images Late last year, software automation firm UiPath ( PATH ) traded as close as around $20. In January, sellers emerged, continuing to dump the stock in February. In March, when the company posted fiscal fourth-quarter results, PATH stock fell again. The stock potentially found a trading range at around $10 - $11. Still, bullish investors are not safe. Bears hold a...
bymuratdeniz/iStock via Getty Images Late last year, software automation firm UiPath ( PATH ) traded as close as around $20. In January, sellers emerged, continuing to dump the stock in February. In March, when the company posted fiscal fourth-quarter results, PATH stock fell again. The stock potentially found a trading range at around $10 - $11. Still, bullish investors are not safe. Bears hold a decisive 23.63% short interest on UiPath. What are UiPath’s prospects from here? Fourth-quarter 2026 Results In Q4, UiPath posted revenue of $481.11 million, up by 13.5% Y/Y. Non-GAAP earnings per share of $0.30 beat expectations. The reconciliation of non-GAAP earnings to GAAP includes stock-based compensation of $64.834 million . Compare that to the GAAP net income of $104.46 million, or 62% of the total. At a higher level, investors are scrutinizing stock-based compensation in software companies like Adobe Systems ( ADBE ) or Salesforce ( CRM ). Money flow accelerated into AI hardware firms like Micron Technology ( MU ). That potentially led to an exodus of investors in SaaS names, including UiPath. In the quarter and the year, the company posted strong revenue and annual recurring revenue growth rates of 14%, 13%, and 11%, respectively. UiPath AI Opportunities For UiPath Just as Adobe touted Firefly AI and Salesforce mentioned Agentforce and Einstein AI solutions, UiPath did the same. UiPath The company mentioned in its last conference call four advantages of its product in the agentic era. First is a unified platform that promotes agentic automation, orchestration with governance, and security, all in a full stack. Second, it has thousands of workflows for enterprise customers, all potentially run with agents. Third, the firm has experience with AI and automation. Lastly, UiPath has expertise in a variety of enterprises, from regulatory sectors to industries that demand solutions in a flat, horizontal hierarchy. UiPath ultimately offers an Agentic automation platform ...
watch now VIDEO 6:26 06:26 Uber CEO Dara Khosrowshahi on Q1 results: We're building for the long term here Squawk Box Higher gasoline prices and mounting geopolitical tensions are doing little to slow the American consumer — at least judging by the latest results and commentary from Uber Technologies and The Walt Disney Company . The two companies pointed to a remarkably resilient spending backdro...
watch now VIDEO 6:26 06:26 Uber CEO Dara Khosrowshahi on Q1 results: We're building for the long term here Squawk Box Higher gasoline prices and mounting geopolitical tensions are doing little to slow the American consumer — at least judging by the latest results and commentary from Uber Technologies and The Walt Disney Company . The two companies pointed to a remarkably resilient spending backdrop, with consumers continuing to shell out for rides, food delivery, vacations and theme park trips even as oil prices climb and broader concerns about the economy linger. Shares of Uber surged nearly 10% in premarket trading, while Disney shares popped 5%. "We watched consumer patterns really closely. Are people taking shorter trips? Are people trading down in terms of the size of their grocery basket, so to speak? With the kinds of restaurants that they're eating at, are consumers tipping as much as they were? All of those indicators continue to be really strong," Uber CEO Dara Khosrowshahi said on CNBC's " Squawk Box " Wednesday. "The consumers are spending, they're spending locally, and we don't see any signs of that weakening at this point." At Uber, delivery remained the company's fastest-growing business in the latest quarter, with revenue jumping 34% to $5.07 billion from $3.78 billion a year earlier. Revenue in the ride-hailing division rose 5% to $6.8 billion as commuting activity and local spending stayed strong. Khosrowshahi said Uber is seeing consumers continue to leave their homes more frequently, helped in part by a return-to-office trend that has boosted commuting demand. The company now has more than 10 million earners on its platform globally, including drivers and delivery workers. Loading chart... The same resilience showed up at Disney, where the entertainment giant topped Wall Street expectations on the strength of its streaming and parks businesses. Disney's experiences division, which includes theme parks and cruises, posted nearly $9.5 billion in qu...
The Communist Party chief of Hefei – a growing tech hub and capital of China’s central Anhui province – has been placed under investigation, the country’s top corruption watchdog announced on Wednesday. Fei Gaoyun, once widely recognised as a rising star in the “seventh-generation” of future national leaders, is the latest senior official to be snared in President Xi Jinping’s long-running anti-co...
The Communist Party chief of Hefei – a growing tech hub and capital of China’s central Anhui province – has been placed under investigation, the country’s top corruption watchdog announced on Wednesday. Fei Gaoyun, once widely recognised as a rising star in the “seventh-generation” of future national leaders, is the latest senior official to be snared in President Xi Jinping’s long-running anti-corruption campaign. The 54-year-old’s career trajectory was typical of China’s emerging generation of...
(RTTNews) - While reporting financial results for the second quarter on Wednesday, Johnson Controls International plc (JCI) provided its adjusted earnings and organic sales growth guidance for the third quarter. The company also raised its outlook for the full-year 2026.
(RTTNews) - While reporting financial results for the second quarter on Wednesday, Johnson Controls International plc (JCI) provided its adjusted earnings and organic sales growth guidance for the third quarter. The company also raised its outlook for the full-year 2026.
Star Equity Holdings ( Nasdaq: STRR ) on Wednesday said it has submitted an indication of interest to acquire GEE Group in a stock-for-stock transaction valuing the target’s common shares at $0.30 each. The offer would see Star acquire all outstanding shares of GEE Group using its 10% Series A cumulative perpetual preferred stock, priced at a $10.00 per share liquidation preference. Star, which ow...
Star Equity Holdings ( Nasdaq: STRR ) on Wednesday said it has submitted an indication of interest to acquire GEE Group in a stock-for-stock transaction valuing the target’s common shares at $0.30 each. The offer would see Star acquire all outstanding shares of GEE Group using its 10% Series A cumulative perpetual preferred stock, priced at a $10.00 per share liquidation preference. Star, which owns about 5.4% of GEE Group, said the proposed deal aims to cut public company costs and reduce overhead, and would require GEE management to agree to standard severance arrangements. The proposal is non-binding and subject to approval by GEE Group’s board. Source: Press Release More on Star Equity Holdings Star Equity’s KBS Builders wins $4.2M contract for modular multifamily project in New Hampshire Star Equity outlines 2026 growth plans with Building Solutions and Energy Services poised for recovery Seeking Alpha’s Quant Rating on Star Equity Holdings
相似的包装色调和功效用法、内地和香港不同的版本、不同的销售价格和渠道，这些，会不会让你陷入“选择困难症”？ 一瓶只用了薄荷、乙醇两个简单成分的药水，被两家公司抢夺，围绕“谁真谁假”问题吵得不可开交，商标官司的案子更是从2014年打到现在，成为功能性外用产品领域的一桩悬案。 这，就是在华南地区拥有一定市场知名度的“双飞人”药水。 近期，随着保健品领域“优思益”事件的爆发，“双飞人”药水也再次因“真假”问题引发消费者关注。 这真的是一款万灵“神药”吗？真的是传言中的来自法国吗？产品是如何进入中国并产生争议的？内地和香港之间的商标之争又是因何而起的？ 我们多方查证，努力还原“双飞人”的前世今生。 01 “利佳制药厂”有名无实 目前，市面上在售（线上、线下）的“双飞人”产品主要有两款，一款是标注为法国利佳制药厂出品，由香港全球药业经销的“雙飛人药水”；另一款则是由双飞人制药股份有限公司（注册地：江西省樟树市；下称“江西双飞人”）出品的“双飞人爽水”。 截图来源于小红书 另外，还有一款名为“利佳薄荷水”的产品。该款产品宣称与雙飛人药水同厂同配方，同样由法国利佳制药厂出品，香港全球药业的相关公司广州赖特斯商务咨询有限公司（下称“广州赖特斯”）负责销售。 截图来源于小红书 我们首先来看在香港销售多年的雙飛人药水。 二十世纪七十年代，一款名为“Ricqlès”的法国薄荷利口酒出现在香港。由于产品外包装上印着的“Ricqlès”名称对于香港人有点陌生，香港全球药业便根据包装上两个带翅膀的天使小人形象，给商品起名叫“雙飛人”。 为了能宣传药用功效，全球药业将Ricqlès注册为药剂制品。香港药物办公室网站显示，该药物注册时间是1979年，药剂制品编号 HK-03206，持有人为 THE INTERNATIONAL MEDICAL COMPANY LIMITED (全球药业有限公司)，产品名称为ALCOHOL DE MENTHE DE RICQLES，分类为非处方药，成分是酒精、薄荷油。 当Ricqlès这款产品在香港有了“药水”身份后，它与法国老家的关系就日渐疏远了。要知道，Ricqlès在法国是一款薄荷利口酒，始终以酒水、食品的名义销售。 1987年，Ricqlès被德国糖果业巨头Haribo集团收购，公司名称变为了“Haribo Ricqles Zan”。产品还是那款薄荷酒，但进口...